CONMED Corporation (CNMD) Dividend History

CONMED Corporation (CNMD) is a medical technology company that develops and manufactures surgical and patient monitoring products. Founded in 1970, it focuses on minimally invasive surgical solutions, orthopedics, and other medical devices used in various healthcare settings to improve patient outcomes.

11311 Concept Boulevard, Largo, FL, 33773
Phone: 727-214-2974
Website: https://www.conmed.com
Dividend Yield: 1.61%
Dividend Frequency: Quarterly

Dividend History

Pay Date Amount Ex Dividend Date Record Date
July 03, 2025 $0.20 06/13/2025 06/13/2025
April 04, 2025 $0.20 03/14/2025 03/14/2025
January 03, 2025 $0.20 12/20/2024 12/20/2024
October 04, 2024 $0.20 09/16/2024 09/16/2024
July 05, 2024 $0.20 06/14/2024 06/14/2024
Show more

Dividends Summary

  • CONMED Corporation has issued 54 dividend payments over the past 13 years
  • The most recent dividend was paid 20 days ago, on July 3, 2025
  • The first recorded dividend was paid on April 5, 2012
  • The highest dividend payout was $0.20 per share
  • The average dividend over this 13 year span is $0.19 per share
  • CONMED Corporation has increased its dividend payments by 33.33% since 2012

Company News

  • The operating room equipment market is experiencing strong growth, driven by the increasing volume of surgical procedures and the growing incidence of chronic diseases, particularly among the aging population. North America is expected to dominate the market, with technological advancements and investments in research and development by key players fueling the demand for cutting-edge operating room equipment.

    GlobeNewswire Inc.
    Featured Companies: BAX GEHC ICUI ISRG JNJ MDT PHG STE SYK
  • CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.

    Zacks Investment Research
    Featured Companies: DVA HOLX RMD
  • Ratings for Conmed (NYSE:CNMD) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 1 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 2 1 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $109.8, a high estimate of $129.00, and a low estimate of $98.00. A decline of 11.45% from the prior average price target is evident in the current average. Exploring Analyst Ratings: An In-Depth Overview A comprehensive examination of how financial experts perceive Conmed is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Mike Matson Needham Lowers Buy $107.00 $129.00 Matt O'Brien Piper Sandler Lowers Overweight $100.00 $130.00 Robbie Marcus JP Morgan Lowers Overweight $115.00 $135.00 Durgesh Chopra Wells Fargo Lowers Equal-Weight $98.00 $107.00 Mike Matson Needham Raises Buy $129.00 $119.00 Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their ...Full story available on Benzinga.com

    Benzinga
  • Insulet and Conmed ought to be medtech's shining stars in 2023.

    The Motley Fool
    Featured Companies: PODD
Page data last updated 07/23/2025 17:06:25 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included